Clinical significance of the long-term symptom-modifying effects of glucosamine sulfate: comment on the article by Brandt and Mazzuca

被引：4

作者：

Bruyere, Olivier ^{[1
]}

Reginster, Jean-Yves

Giacovelli, Giampaolo

Barbetta, Beatrice

Rovati, Lucio C.

Pavelka, Karel

机构：

[1] Univ Liege, Liege, Belgium

[2] Rottapharm, Monza, Italy

[3] Inst Rheumatol, Prague, Czech Republic

来源：

ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 07期

关键词：

D O I：

10.1002/art.21867

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2339 / 2341

页数：3

共 9 条

[1]

BELLAMY N, 1995, WOMAC OSTEROARTHRITI

[2] Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs [J].

Brandt, KD ;

Mazzuca, SA .

ARTHRITIS AND RHEUMATISM, 2005, 52 (11) :3349-3359

[3]

Ehrich EW, 2000, J RHEUMATOL, V27, P2635

[4]

GIACOVELLI G, 2005, OSTEOARTHRITIS CAR S, V12, pP129

[5] Glucosamine sulfate use and delay of progression of knee Osteoarthritis -: A 3-year, randomized, placebo-controlled, double-blind study [J].

Pavelká, K ;

Gatterová, J ;

Olejarová, M ;

Machacek, S ;

Giacovelli, G ;

Rovati, LC .

ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (18) :2113-2123

[6] Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial [J].

Reginster, JY ;

Deroisy, R ;

Rovati, LC ;

Lee, RL ;

Lejeune, E ;

Bruyere, O ;

Giacovelli, G ;

Henrotin, Y ;

Dacre, JE ;

Gossett, C .

LANCET, 2001, 357 (9252) :251-256

[7] Glucosamine therapy for treating osteoarthritis - art. no. CD002946.pub2 [J].

Towheed, TE ;

Maxwell, L ;

Anastassiades, TP ;

Shea, B ;

Houpt, J ;

Robinson, V ;

Hochberg, MC ;

Wells, G .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (02)

[8] Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state [J].

Tubach, F ;

Ravaud, P ;

Baron, G ;

Falissard, B ;

Logeart, I ;

Bellamy, N ;

Bombardier, C ;

Felson, D ;

Hochberg, M ;

van der Heijde, D ;

Dougados, M .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) :34-37

[9] Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement [J].